Cargando…
Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer
BACKGROUND: Multidrug resistance (MDR) is the major reason for the failure of chemotherapy in colon cancer. Bufalin (BU) is one of the most effective antitumor active constituents in Chansu. Our previous study found that BU can effectively reverse P-glycoprotein (P-gp)-mediated MDR in colon cancer....
Autores principales: | Yuan, Zeting, Yuan, Yuxia, Han, Lin, Qiu, Yanyan, Huang, Xiaqin, Gao, Feng, Fan, Guohua, Zhang, Yixi, Tang, Xueyao, He, Xue, Xu, Ke, Yin, Peihao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241863/ https://www.ncbi.nlm.nih.gov/pubmed/30532537 http://dx.doi.org/10.2147/IJN.S170692 |
Ejemplares similares
-
cRGD-Conjugated Fe(3)O(4)@PDA-DOX Multifunctional Nanocomposites for MRI and Antitumor Chemo-Photothermal Therapy
por: Fan, Xi, et al.
Publicado: (2019) -
Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signalling pathway
por: Fang, Kai, et al.
Publicado: (2021) -
Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity
por: Yin, Peihao, et al.
Publicado: (2012) -
Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor‐κB/MDR1 pathway in colorectal cancer
por: Zhan, Yueping, et al.
Publicado: (2020) -
Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes
por: Yuan, Jiani, et al.
Publicado: (2017)